1. Home
  2. CYTK vs FMC Comparison

CYTK vs FMC Comparison

Compare CYTK & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • FMC
  • Stock Information
  • Founded
  • CYTK 1997
  • FMC 1910
  • Country
  • CYTK United States
  • FMC United States
  • Employees
  • CYTK N/A
  • FMC N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • FMC Major Chemicals
  • Sector
  • CYTK Health Care
  • FMC Industrials
  • Exchange
  • CYTK Nasdaq
  • FMC Nasdaq
  • Market Cap
  • CYTK 4.6B
  • FMC 4.6B
  • IPO Year
  • CYTK 2004
  • FMC N/A
  • Fundamental
  • Price
  • CYTK $35.39
  • FMC $39.03
  • Analyst Decision
  • CYTK Buy
  • FMC Buy
  • Analyst Count
  • CYTK 13
  • FMC 12
  • Target Price
  • CYTK $71.58
  • FMC $50.58
  • AVG Volume (30 Days)
  • CYTK 1.7M
  • FMC 1.7M
  • Earning Date
  • CYTK 08-07-2025
  • FMC 10-28-2025
  • Dividend Yield
  • CYTK N/A
  • FMC 5.93%
  • EPS Growth
  • CYTK N/A
  • FMC N/A
  • EPS
  • CYTK N/A
  • FMC 0.80
  • Revenue
  • CYTK $85,738,000.00
  • FMC $4,131,600,000.00
  • Revenue This Year
  • CYTK $330.96
  • FMC $0.26
  • Revenue Next Year
  • CYTK $73.41
  • FMC $4.72
  • P/E Ratio
  • CYTK N/A
  • FMC $37.77
  • Revenue Growth
  • CYTK 2635.74
  • FMC 1.16
  • 52 Week Low
  • CYTK $29.31
  • FMC $32.83
  • 52 Week High
  • CYTK $59.39
  • FMC $67.75
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 49.60
  • FMC 50.21
  • Support Level
  • CYTK $36.89
  • FMC $38.84
  • Resistance Level
  • CYTK $39.92
  • FMC $39.99
  • Average True Range (ATR)
  • CYTK 1.78
  • FMC 0.99
  • MACD
  • CYTK -0.06
  • FMC 0.35
  • Stochastic Oscillator
  • CYTK 54.96
  • FMC 73.58

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About FMC FMC Corporation

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

Share on Social Networks: